Company profile: Nutrasource
1.1 - Company Overview
Company description
- Provider of clinical trial management, regulatory support, third-party certification programs for natural ingredients (NutraStrong, IFOS, IKOS, IAOS, IGEN, IPRO, Radioactivity Tested & Certified), analytical method development, quality control release testing, and formulation validation support testing to help health product companies bring products to market with trust, confidence, strong science, and regulatory credibility.
Products and services
- Regulatory Support Services: Delivers compliance-focused guidance on regulatory affairs to ensure health products meet necessary legal requirements and compliance standards
- Clinical Trial Management: Supplies comprehensive management of clinical trials, including study design, site selection, and oversight of regulatory compliance for market-ready health products
- Product Certifications: Offers third-party programs for natural ingredients, including NutraStrong, IFOS, IKOS, IAOS, IGEN, IPRO, and Radioactivity Tested & Certified
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Nutrasource
Syrrx
HQ: United States
Website
- Description: Provider of drug discovery services leveraging high-throughput structural biology, focusing on drug targets validated in human clinical trials and directing efforts toward therapeutics for metabolic diseases, cancer, and inflammation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Syrrx company profile →
Aliada Therapeutics
HQ: United States
Website
- Description: Provider of biotechnology therapies for central nervous system diseases, leveraging the MODEL platform to deliver large molecules across the blood-brain barrier via small modular protein domains. Offerings include ALIA-1758, a bispecific antibody targeting pyroglutamate amyloid beta and TfR for potentially clearing amyloid beta plaques in Alzheimer’s disease, and partner programs to develop brain-accessible therapeutics for lysosomal storage disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aliada Therapeutics company profile →
Adams Clinical
HQ: United States
Website
- Description: Provider of late-phase psychiatric and neurologic clinical trials in Massachusetts, conducting double-blind, randomized, placebo-controlled studies on investigational drugs. Also runs open-label depression monitoring (TRAIT-MDD-107) and Alzheimer's studies: ABBV-552 (M23-515 AbroAD) for mild AD and remternetug (J1G-MC-LAKC TRAILRUNNER-ALZ-1) for early symptomatic AD.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adams Clinical company profile →
Zwiers Regulatory
HQ: The Netherlands
Website
- Description: Provider of consulting services focused on integrated development for pharmaceuticals and devices, pharmacovigilance, and regulatory affairs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Zwiers Regulatory company profile →
US Pharma Lab
HQ: United States
Website
- Description: Provider of custom development, manufacturing, and supply services for premium dietary supplement ingredients, premixes, and products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full US Pharma Lab company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Nutrasource
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Nutrasource
2.2 - Growth funds investing in similar companies to Nutrasource
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Nutrasource
4.2 - Public trading comparable groups for Nutrasource
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →